Mammalian myeloid progenitor cell subsets

Details Mammalian myeloid progenitor cell subsets Mammalian myeloid progenitor cell subsets

2001-09-17

2004-07-13

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

C424S093700, C435S325000, C435S366000, C435S372000, C435S391000, C435S405000, C435S002000

Reexamination Certificate

active

06761883

ABSTRACT:

BACKGROUND OF THE INVENTION
The mammalian immune system plays a vital role in protection from disease, but its effectiveness rests on the equilibrium between different responses. Excessive or inappropriate responses can result in autoimmune disease, while a failure to respond results in immunodeficiency. When such conditions occur, therapeutic intervention may be required.
The mature cells of the immune system, T cells, B cells and natural killer cells, continually differentiate from hematopoietic stem cells, through a series of cell divisions. It is believed that after each cell division the developmental potential of the daughter cells is either maintained or further restricted relative to the parent, never expanded. One therefore observes that pluripotential stem cells give rise to multi-lineage committed progenitor cells, which give rise to specific lineages and finally mature cells. The coordinated changes of cellular properties leading to irreversible restriction of lineage commitment may be due to sequential activation or silencing of various genes.
The phenotype of long-lived pluripotential hematopoietic stem cells has been described. However, the identification of intermediate bipotent or oligopotent progenitors has been difficult, since the evaluation of differentiating potential may be perturbed by a possible failure for the cells to read out detectable differentiation to particular lineages, which may be due to failure in reaching suitable microenvironments in vivo, an insufficient expansion for detection in vivo, or the stochastic nature of lineage commitment, at least in vitro.
The use of pluripotential or lineage committed progenitor cells circumvents many of the problems that would arise from the transfer of mature cells. However, such progenitor cells must be separated from other hematopoietic cells. Separation requires identification of the cell and characterization of phenotypic differences that can be utilized in a separation procedure. Cells that are amenable to genetic manipulation are particularly desirable.
Relevant Literature
A number of review articles have been published addressing the phenotype of cells in hematopoietic lineages. Overall development of the hematolymphoid system is discussed in Orkin (1996)
Curr. Opin. Genet. Dev.
6:597-602. The role of transcriptional factors in the regulation of hematopoietic differentiation is discussed in Georgopoulos et al. (1997)
Annu. Rev. Immunol.
15:155-176; and Singh (1996)
Curr. Opin. Immunol.
8:160-165.
The phenotype of hematopoietic stem cells is discussed in Morrison & Weissman (1994)
Immunity
1, 661-673; Spangrude et al. (1988)
Science
241, 58-62; Enver et al. (1998)
Blood
92, 348-351; discussion 352; Uchida et al. (1994)
Blood
83, 3758-3779; Morrison et al. The aging of hematopoietic stem cells.
Nat Med
2, 1011-1016 (1996).
The phenotype of a common lymphoid progenitor cell is discussed by Kondo et al. (1997)
Cell
91, 661-672. The role of Bcl-2 in lymphopoiesis is discussed in Akashi et al. (1997)
Cell
89, 1033-1041. Lineage commitment and maturation is discussed by Metcalf (1998)
Blood
92, 345-347; discussion 352. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia; Traver et al. (1998)
Immunity
9, 47-57 (1998). Multipotent progenitors in acute myelogenous leukemia are described by Miyamoto, et al. (1996)
Blood
87, 4789-4796.
The transcription factor GATA-1 is described by Shivdasani (1997)
Embo J
16, 3965-3973 (1997); Pevny et al. (1991)
Nature
349, 257-260. Zon et al. (1991)
P.N.A.S.
88, 10638-10641.
SUMMARY OF THE INVENTION
A substantially enriched mammalian hematopoietic cell subpopulation is provided, which is characterized by progenitor cell activity for myeloid lineages, but lacking the potential to differentiate into lymphoid lineages. This population is called the common myeloid progenitor cell (CMP). Methods are provided for the isolation and culture of these subpopulations. The CMP population gives rise to all myeloid lineages, and can give rise to two additional progenitor populations that are exclusively committed to either the erythroid/megakaryocytic (MEP) or myelomonocytic lineages (GMP). Both MEP and GMP can be substantially enriched, isolated and cultured. The three progenitor populations are useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products, including mRNA species useful in identifying genes specifically expressed in these cells, and as targets for the discovery of factors or molecules that can affect them.


REFERENCES:
patent: 5808002 (1998-09-01), Buhring
patent: 5821108 (1998-10-01), Akashi et al.
patent: 5843633 (1998-12-01), Yin et al.
patent: 5905041 (1999-05-01), Beug et al.
patent: WO 99/10478 (1999-03-01), None
Akashi et al. (1997), “Bcl-2 Rescues T Lymphocytes in Interleukin-7 Receptor-Deficient Mice.”Cell, vol. 89:1033-1041.
Enver et al. (Jul. 15, 1998), “Do Stem Cells Play Dice?”Blood, vol. 92(2):348-351.
Georgopoulos et al. (1997), “The Role of the Ikaros Gene in Lymphocyte Development and Homeostasis.”Annu. Rev. Immunol., vol. 15:155-176.
Heimfeld et al. (Nov. 1991), “The in vitro Response of Phenotypically Defined Mouse Stem Cells and Myeloerythroid Progenitors to Single or Multiple Growth Factors.”Proc. Natl. Acad. Sci. USA, vol. 88:9902-9906.
Metcalf, Donald (Jul. 15, 1998), “Lineage Commitment and Maturation in Hematopoietic Cells: The Case for Extrinsic Regulation.”Blood, vol. 92(2):345-352.
Kondo et al. (Nov. 28, 1997), “Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow.”Cell, vol. 91:661-672.
Magli et al. (Feb. 11, 1982), “Transient Nature of Early Hematopoeitic Spleen Colonies.”Nature, vol. 295:527-529.
Miyamoto et al. (Jun. 1, 1996), “Persistence of Multipotent Progenitors Expressing AML1/ETO Transcripts in Long-Term Remission Patients with t(8;21) Acute Myelogenous Leukemia.”Blood, vol. 87(11):4789-4796.
Morrison et al. (Sep. 1996), “The Aging of Hematopoietic Stem Cells.”Nature Medicine, vol. 2(9):1011-1016.
Morrison et al. (Nov. 1994), “The Long-Term Repopulating Subset of Hematopoietic Stem Cells is Deterministic and Isolatable by Phenotype.”Immunity, vol. 1:661-673.
Ogawa, Makio (Jun. 1, 1993), “Differentiation and Proliferation of Hematopoietic Stem Cells.”Blood, vol. 81(11):2844-2853.
Orkin, Stewart (1996), “Development of the Hematopoietic System.”Current Biology, vol. 6:597-602.
Pevny et al. (Jan. 17, 1991), “Erythroid Differentiation in Chimaeric Mice Blocked by a Targeted Mutation in the Gene for Transcription Factor GATA-1.”Nature, vol. 349:257-260.
Shivdasani et al. (1997). “A Lineage-Selective Knockout Establishes the Critical Role of Transcription Factor GATA-1 in Megakaryocyte Growth and Platelet Development.”The EMBO Journal, vol. 16(13):3965-3973.
Siminovitch et al. (Dec. 1963), “The Distribution of Colony-Forming Cells Among Spleen Colonies.”Journal of Cellular and Comparative Physiology, vol. 62(3):327-336.
Singh, Harinder (1996), “Gene Targeting Reveals a Hierarchy of Transcription Factors Regulating Specification of Lymphoid Cell Fates.”Current Biology, vol. 8:160-165.
Spangrude et al. (Jul. 1, 1988), “Purification and Characterization of Mouse Hematopoietic Stem Cells.”Science, vol. 241:58-62.
Suda et al. (Aug. 1984), “Analysis of Differentiation of Mouse Hematopoietic Stem Cells in Culture by Sequential Replating of Paired Progenitors.”Blood, vol. 64(2):393-399.
Traver et al. (Jul. 1998), “Mice Defective in Two Apoptosis Pathways in the Myeloid Lineage Develop Acute Myeloblastic Leukemia.”Immunity, vol. 9:47-57.
Uchida et al. (Jun. 15, 1994), “Rapid and Sustained Hematopoietic Recovery in Lethally Irradiated Mice Transplaned with Purified Thy-1.1loLin−Sca-1+Hematopoietic Stem Cells.”Blood, vol. 83(12):3758-3779.
Zon et al. (Dec. 1991), “Activation of the Erythropoietin Receptor Promoter by Transcription Factor GATA-1.”Proc. Natl. Acad. Sci. USA, vol. 88:10638-10641.
Akashi, Koichi et al., A Clonogenic Common Myeloid Progenitor That Gives Rise to all My

Affiliated with

Also associated with

Rating

Mammalian myeloid progenitor cell subsets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mammalian myeloid progenitor cell subsets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian myeloid progenitor cell subsets will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3256199